Tear trough filler with hyaluronic acid: clinical guide
Tear trough filler with hyaluronic acid applies only when there is volume loss in the tear trough. Learn its indications, limits, and warning signs.

Sunken under-eyes and hyaluronic acid: what the technique can and cannot do
Tear trough filler with hyaluronic acid is one of the most frequently requested procedures in aesthetic medicine, and also one of the most misunderstood. The question we hear most often is straightforward: does hyaluronic acid work for under-eye concerns? So is the answer: it depends on what is causing them. There is no single type of under-eye concern, and the technique responds to only one of them.
Before discussing needles and hyaluronic acid, it is important to understand what is happening beneath the skin. The periocular area is anatomically complex: it contains vessels of significant caliber, adipose tissue organized into compartments, and some of the thinnest skin on the body. That makes it a zone requiring clinical judgment, not routine.
The four types of under-eye concerns: why diagnosis drives everything
Distinguishing the origin of an under-eye concern is not a preliminary step to treatment: it is the treatment. A periocular assessment aims to identify which of these mechanisms predominates, because each one responds to a different intervention.
Under-eye concerns from tear trough volume loss
This is the primary indication for tear trough filler with hyaluronic acid. The tear trough is the fold that marks the junction between the lower eyelid and the cheek. When there is volume loss in that area, whether from hereditary factors or age-related changes, a crescent-shaped shadow forms that gives the appearance of dark under-eyes. Here, hyaluronic acid can restore that volume and reduce the shadow.
Under-eye concerns from pigmentation
The periocular skin may carry higher melanin levels constitutionally, through accumulated sun exposure, or as a result of certain hormonal changes. In these cases, the color exists regardless of whether there is volume loss or not. Injectable hyaluronic acid does not modify melanin: adding volume over pigmentation does not correct it and may make the area more prominent.
Under-eye concerns from visible vessels
Very thin lower-eyelid skin allows the underlying vessels to show through, producing a bluish or purplish tone. This is not an absence of volume: it is tissue transparency. Filler does not change the thickness or opacity of the skin, so this variant is not an indication for this technique either.
Under-eye concerns from lower-eyelid puffiness
Lower-eyelid puffiness occurs when orbital fat protrudes forward due to weakening of the orbital septum. Here there is excess volume, not a deficit. Adding hyaluronic acid in this area can worsen the appearance of swelling. Blepharoplasty is the surgical path available for this, and the decision belongs to an oculoplastic or facial plastic surgery specialist.
The under-eye concern that looks like a shadowed hollow, deeper than it is dark, is the one that responds to injectable hyaluronic acid. The others require a different conversation.
Tear trough filler with hyaluronic acid: what happens in a session
In general, a tear trough filler session involves placing small amounts of low-density hyaluronic acid in the supraperiosteal or submuscular plane, depending on each person's anatomy and the clinician's judgment. The periocular area demands precise technique: the volumes are small and placement matters as much as the material itself.
The periocular skin responds with some degree of swelling during the first days. This is expected. The area has limited mechanical support and the tissue retains water readily, particularly around newly placed hyaluronic acid. That initial swelling does not reflect the final result.
What to expect realistically
When the indication is correct, the typical outcome is a reduction of the shadow produced by the volume deficit. The expectation should not be that the under-eye concern disappears entirely: the skin remains the same, pigmentation does not change, and the underlying vessels stay in place. What changes is the geometry of the area, and that can be enough to produce a visible difference.
How long the effect lasts varies between individuals. The periocular area has high mobility and vascularization, which accelerates hyaluronic acid degradation compared with other areas. No one can promise a permanent result or a fixed duration.
Risks of periocular filler: hyaluronic acid in a high-care zone
The periocular area concentrates vessels of clinical significance. The most serious risk of filler in this area is vascular occlusion: if the material obstructs a vessel, the tissue supplied by that vessel may be compromised. This event is not common, but its consequences are serious and the window for intervention is narrow.
Any clinician performing periorbital filler must have hyaluronidase available and be prepared to use it immediately. This enzyme dissolves hyaluronic acid and is the primary response tool for an occlusion. Its availability is not optional: it is part of the minimum standard for this procedure.
Warning signs that require emergency attention
There are signs that cannot wait and should not be managed by messaging a clinic. If any of the following symptoms appear after a periocular injection, you must go to an emergency department immediately:
- Sudden changes in vision: blurred vision, double vision, partial or total loss of the visual field.
- Skin that turns white or purplish in the injected area or on the eyelid, which may indicate vascular compromise.
- Intense, disproportionate pain in the area or around the eye.
- New neurological symptoms: sudden dizziness, difficulty speaking, weakness on one side of the body.
- Difficulty breathing or chest pain in the period following the procedure.
These symptoms represent a medical emergency. Timely attention at an emergency department makes the difference in the outcome.
Persistent swelling: when it warrants attention
Some degree of swelling during the first days is expected. What warrants follow-up is swelling that does not subside, that increases after the third or fourth day, or that appears with marked asymmetry. Hardening of the area, pain that does not improve, or changes in the skin such as atypical coloration or irregular texture are also signs that call for a clinical consultation.
The periocular area does not tolerate improvisation. Clinical judgment in the indication carries as much weight as technique in the application.
The periocular assessment: how we determine whether filler applies
Candidacy for tear trough filler with hyaluronic acid is established through an assessment that includes inspection of the skin, evaluation of subcutaneous volume, presence or absence of puffiness, skin tone, and the vascular condition of the area. No list of symptoms confirms the indication on its own.
That same assessment reviews relevant medical history: tendency to swell, use of anticoagulants or antiplatelet agents, prior ocular or eyelid surgery, and any condition that may affect healing or the response to the material. All of that forms part of the clinical judgment.
The plan in writing
When the indication is clear, the plan is delivered in writing. That document specifies what is proposed, which material will be used, how many sessions are involved, and what follow-up is planned. There are no universal protocols for the tear trough: the volume, the density of the hyaluronic acid, and the number of sessions depend on individual anatomy.
At Longevia Medical in Puerto Cancún, care begins with an assessment, which can be in person or remote. If that assessment concludes that periocular filler is the appropriate indication, the plan is delivered in writing. Follow-up continues when the patient returns home.
flowchart TD
A["Consultation for under-eye concerns"] --> B["Periocular assessment"]
B --> C{"What is the origin?"}
C --> D["Tear trough volume loss"]
C --> E["Predominant pigmentation"]
C --> F["Lower-eyelid puffiness"]
C --> G["Visible vessels, thin skin"]
D --> H["Tear trough filler with hyaluronic acid: possible indication"]
E --> I["Other options: depigmentation, sun protection, peeling"]
F --> J["Assessment with oculoplastic surgeon"]
G --> K["No indication for filler in this variant"]
H --> L["Detailed anatomical assessment and written plan"]
Injectable hyaluronic acid in the periocular area: what the evidence supports and what it does not
The use of injectable hyaluronic acid to restore volume in the tear trough is accepted in aesthetic medicine practice, based on its behavior in soft tissue and its reversibility. It is not an experimental procedure when the indication is correct and the clinician performing it has the appropriate training.
What remains under study is the optimal durability according to hyaluronic acid type, the safest injection planes to reduce vascular risk, and the protocols for correction when persistent swelling or nodules appear. The field is advancing, but no one yet has a definitive answer on the ideal technique for every anatomy.
What does not apply is using periocular filler to treat under-eye concerns of pigmentary, vascular, or orbital fat origin. In those cases, the procedure does not address the problem and can introduce unnecessary variables. To understand the difference between the filler materials available and their general indications, you can review our guide on evidence and limits in regenerative medicine, which follows the same principle: every tool has its indication and its boundaries.
A reversible procedure, in expert hands and with the correct indication, is still a procedure with real risks. Understanding that is part of informed decision-making.
Frequently asked questions about tear trough filler with hyaluronic acid
Frequently Asked Questions
Does hyaluronic acid work for all types of under-eye concerns?
No. Tear trough filler with hyaluronic acid responds only to volume loss in the tear trough. Under-eye concerns caused by pigmentation, visible vessels, or lower-eyelid puffiness have a different origin and require a different approach. Applying filler where it does not belong does not improve the outcome and can complicate it.
How long does the effect of hyaluronic acid in the tear trough last?
The periocular area has high mobility and vascularization, which accelerates material degradation. Duration varies between individuals and no fixed timeline can be promised. Follow-up and individual assessment determine whether retreatment is needed and when.
Is periocular filler with hyaluronic acid reversible?
Yes. Hyaluronic acid can be dissolved with hyaluronidase, an enzyme the clinician must have available during the procedure. This reversibility is a clinical advantage, but it does not eliminate the importance of the correct indication or expert management of the area.
What warning signs should I know about after tear trough filler?
Any sudden change in vision, white or purplish skin around the eye, intense pain, or new neurological symptoms after a periocular injection require immediate emergency attention. Notifying the clinic is not sufficient: go to an emergency department without delay.
How do I know if I am a candidate for tear trough filler with hyaluronic acid?
Candidacy is determined through a clinical assessment, not by symptoms or photographs alone. The type of under-eye concern, the anatomy of the area, skin tone, the presence of puffiness, and relevant medical history are all evaluated. If the indication is appropriate, the plan is delivered in writing.
For those researching this topic in greater depth, Mayo Clinic and MedlinePlus offer general information on filler procedures and periocular skin care that can complement this reading.
Begin privately
Tell us what you want to protect.
This first conversation is for orientation, not diagnosis. A coordinator will identify the right clinical pathway and explain the secure next step.
Request a private consultation↗